Drug intelligence / Profile preview

Andronil

Development stage: Unknown
Lead developer: Pillcraft Advance Remedies
Administration: Oral

Overview

Andronil is an Ayurvedic herbal formulation developed by Pillcraft to support women's wellness, specifically for managing hormonal imbalances, polycystic ovary syndrome (PCOS), polycystic ovary disease (PCOD), menstrual cramps, and lower back pain. The formulation contains equal parts (160 mg each) of Hemp Leaf, Aloe Vera, Lotus stem, and Apamarga. Andronil is designed to regulate metabolic dysfunction, restore endocannabinoid system (ECS) dysregulation, and modulate the hormone release activity of the pituitary gland. It is rich in antioxidants and possesses anti-inflammatory properties.

Brand names: Andronil

Beyond the preview

Go deeper on Andronil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Andronil.

Explore the full profile